Skip to content
49

übelkeit

Skip it

Brand-locked demand (top 5 brands take 94% of clicks) — this niche doesn't clear our bar today.

Market size 55Growth 30Conversion 97Competition 18Returns 100Price range 60Avg price 59Brand share 15Review moat 87Quality gap 23

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible14.6%

search→purchase rate — share of searches ending in a sale

Review moat

Great257.92

avg incumbent reviews — the moat a new listing must climb

Price range

Good€5.05–€30.13

cheapest to priciest tracked listing — scored on the share inside $15–$100

Avg price

Good€13.13

avg listing price — sweet spot $15–$100

Market size

Good€394K

€394K/yr · 206K searches

Growth

Okay+4.1%

90-day search growth — must beat 0% to launch

Quality gap

Bad4.6★

avg incumbent rating — lower means beatable quality

Competition

Bad78%

top-5 click share — a locked-up shelf

Brand share

Bad94%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 78% of clicks — a locked-up shelf that new listings rarely crack.

Brands

7 flat

Sellers

26

Top-5 brand share

94%

Open market

3%

  • Vomex A67%
  • Hexal12%
  • AL Aliud Pharma7%
  • Faar Apo5%
  • APOTHEKEN-EXPRESS3%
  • Klinge Pharma GmbH3%
  • Open — no brand owns it (1 brand, 3%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%15%€59K30%€118K45%€177K60%€237K101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 12 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — +4.1% search growth over the last 90 days.
5K4KSpike '25Prime Day '25Spike '26SepDecMarJunAugNovMarMay

No pronounced peak months · busiest ÷ quietest = 1.3×